ARCHIVE

• NEW PRODUCTS
  June 28, 2004

• Need for New Drug Pricing System Stressed: Korosho Conference
  June 28, 2004

• ICH Topics Q8, Q9 Should Reach Step 2 in November
  June 28, 2004

• REGULATORY NEWS IN BRIEF
  June 28, 2004

• 40,000 May Have Died Due to Medical Malpractice in 2003: Symposium
  June 28, 2004

• Nearly 80% of Public Hospitals Posted Deficits in FY2002
  June 28, 2004

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  June 28, 2004

• Drug Makers to Be Asked for Pharmacogenomics Research Data: JPMA-ABPI Symposium
  June 28, 2004

• Diovan Shows Efficacy Equivalent to Amlodipine in VALUE Study: Novartis
  June 28, 2004

• NBI to Make Micardis Top 3 ARB: Mr Ohsawa
  June 28, 2004

• Pfizer Japan Stresses Efficacy of Amlodipine in VALUE Study
  June 28, 2004

• BULLETIN
  June 28, 2004

• Lamivudine Prevents Liver Cancer in Hepatitis B Patients: JSH Meeting
  June 28, 2004

• 70% of Subjects Express Affirmative View of Trials: JPMA Survey
  June 28, 2004

• PRESS SEMINAR
  June 28, 2004

• FJPWA Working to Ensure Proper Contracts with Medical Institutions
  June 28, 2004

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  June 28, 2004

• Sumitomo to Beef Up Promotional Efforts for Lullan
  June 21, 2004

• Renal Function Improved by Concomitant ACEI, ARB:JSN Meeting
  June 21, 2004

• Teijin Pharma Looking for M&A Opportunity: Mr Ohyagi
  June 21, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 524
• 525
• 526
• 527
• 528
• 529
• 530
• 531
• 532
• …
• Next ›
• 最終 »